These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33040718)

  • 1. Inactivation of Epigenetic Regulators due to Mutations in Solid Tumors.
    Nemtsova MV; Mikhaylenko DS; Kuznetsova EB; Bykov II; Zamyatnin AA
    Biochemistry (Mosc); 2020 Jul; 85(7):735-748. PubMed ID: 33040718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulation of epigenetic mechanisms in cancer.
    Maleszewska M; Wojtas B; Kamińska B
    Postepy Biochem; 2018 Oct; 64(2):148-156. PubMed ID: 30656897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes.
    Van Tongelen A; Loriot A; De Smet C
    Cancer Lett; 2017 Jun; 396():130-137. PubMed ID: 28342986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis.
    Furuya K; Ikura M; Ikura T
    J Biochem; 2019 Apr; 165(4):297-299. PubMed ID: 30605533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations and epimutations in the origin of cancer.
    Peltomäki P
    Exp Cell Res; 2012 Feb; 318(4):299-310. PubMed ID: 22182599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.
    D'Alessio AC; Szyf M
    Biochem Cell Biol; 2006 Aug; 84(4):463-76. PubMed ID: 16936820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.
    Plass C; Pfister SM; Lindroth AM; Bogatyrova O; Claus R; Lichter P
    Nat Rev Genet; 2013 Nov; 14(11):765-80. PubMed ID: 24105274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
    Haslberger A; Varga F; Karlic H
    Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of novel epigenetic molecular-targeting agents].
    Sowa Y; Sakai T
    Nihon Rinsho; 2015 Aug; 73(8):1263-7. PubMed ID: 26281676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention.
    Shen C; Vakoc CR
    Curr Opin Oncol; 2015 Jan; 27(1):57-63. PubMed ID: 25402979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of chromatin in tumor cells.
    Drobic B; Dunn KL; Espino PS; Davie JR
    EXS; 2006; (96):25-47. PubMed ID: 16383013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting epigenetic modifiers in cancer.
    Holloway AF; Oakford PC
    Curr Med Chem; 2007; 14(24):2540-7. PubMed ID: 17979706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of DNA, RNA and histone methylation in ageing and cancer.
    Michalak EM; Burr ML; Bannister AJ; Dawson MA
    Nat Rev Mol Cell Biol; 2019 Oct; 20(10):573-589. PubMed ID: 31270442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in cancer: Fundamentals and Beyond.
    Biswas S; Rao CM
    Pharmacol Ther; 2017 May; 173():118-134. PubMed ID: 28188812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alterations in carcinogenesis.
    Sugimura T; Ushijima T
    Mutat Res; 2000 Apr; 462(2-3):235-46. PubMed ID: 10767635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered primary chromatin structures and their implications in cancer development.
    Ferraro A
    Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic drivers of genetic alterations.
    Toyota M; Suzuki H
    Adv Genet; 2010; 70():309-23. PubMed ID: 20920753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.